Piramal Pharma Q3 Results | Net profit tanks 63% to ₹4 crore, revenue climbs 13% to ₹2,204 crore

Share it

Shares of Piramal Pharma Ltd ended at ₹218.95, down by ₹5.05 or 2.25% on the BSE.

Leave a Comment

Your email address will not be published. Required fields are marked *